Detalhe da pesquisa
1.
Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1.
Bioinformatics
; 2024 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38775719
2.
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines.
Org Biomol Chem
; 22(4): 767-783, 2024 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38167738
3.
Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing Strategy.
Molecules
; 29(7)2024 Mar 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38611732
4.
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021.
J Med Virol
; 95(11): e29193, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37927140
5.
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses.
Bioorg Chem
; 133: 106408, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36801791
6.
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity.
Molecules
; 27(24)2022 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36557962
7.
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells.
J Gen Virol
; 102(1)2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33048041
8.
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
J Antimicrob Chemother
; 76(1): 130-134, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32974670
9.
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021.
Virol J
; 18(1): 168, 2021 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34391446
10.
Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro.
Int J Mol Sci
; 22(5)2021 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33800884
11.
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.
Molecules
; 25(23)2020 Dec 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33287144
12.
Comparable In Vitro Activities of Second-Generation HIV-1 Integrase Strand Transfer Inhibitors (INSTIs) on HIV-1 Clinical Isolates with INSTI Resistance Mutations.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31611362
13.
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro.
J Antimicrob Chemother
; 74(3): 607-613, 2019 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30462235
14.
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.
Virus Genes
; 55(3): 290-297, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30796743
15.
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.
J Clin Lab Anal
; 32(1)2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28303602
16.
Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia.
New Microbiol
; 41(4): 302-305, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30252927
17.
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects.
Infection
; 50(2): 541-543, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34342854
18.
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir.
J Antimicrob Chemother
; 76(12): 3310-3312, 2021 11 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34402509
19.
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season.
J Prev Med Hyg
; 65(1): E11-E16, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38706768
20.
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants.
Viruses
; 16(2)2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38399944